Article Abstract

Stressing the metabolic powers of fibroblast growth factor 21

Authors: Aaron L. Magno, Lakshini Y. Herat, Revathy Carnagarin, Markus P. Schlaich, Vance B. Matthews


The global prevalence of obesity has continued to rapidly increase over the last few decades. As well as the range of metabolic disorders associated with obesity, diseases like diabetes, which was the second leading cause of death related to obesity in 2015, all add to the global burden of disease (1).